BLCO
Bausch + Lomb Corp
NYSE: BLCO · HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES
$16.03
+0.72% today
Updated 2026-06-05
Market cap
$5.38B
P/E ratio
—
P/S ratio
1.03x
EPS (TTM)
$-0.62
Dividend yield
—
52W range
$11 – $19
Volume
0.5M
Bausch + Lomb Corp (BLCO) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$16.03
12-Month target
—
2030 Target
—
Intrinsic (DCF)
$9.60
Financial forecast
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $3.8B | $3.8B | $4.1B | $4.8B | $5.1B |
| EPS | — | — | — | — | — |
CAGR applied: — (capped 20%) · P/E: 25.00x (capped 25x) · Margin: -4.21%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.